Solaris Biotech Shines at Analytica China 2024: Product in The Spotlight
Solaris made a successful debut at Analytica China 2024, held from November 18-20 at the Shanghai New International Expo Centre. The exhibition was a great success, with numerous visitors showing keen interest in Solaris’ innovative bio-manufacturing solutions, including its advanced desktop bioreactors.
Lakshmikanth Mannadi, Sales Director APAC bioprocessing Equipment:
"We were thrilled to announce our participation in Analytica China! We showcased our state-of-the-art bioreactors and advanced automation platform, tailored for scalable solutions in the Chinese market. It was exciting to connect and explore new opportunities!"
Throughout the event, Solaris showcased its IO and Jupiter bioreactors, which attracted a lot of interest for its ability to support both research and large-scale production from attendees across various industries, particularly those from pharmaceutical, food production, and biotechnology sectors.
The Solaris team had the opportunity to engage directly with potential customers, and the response was overwhelmingly positive. Several key discussions focused on the scalability of our solutions, with many visitors intrigued by the dual focus of Solaris’ bioreactors—supporting both R&D and large-scale production. We also had productive conversations on how our technologies align with industry trends toward sustainable, high-efficiency manufacturing.
Solaris Biotech’s successful participation in Analytica China marks a significant step in our expansion in the Asia-Pacific market. The positive response from attendees demonstrates the strong demand for our innovative bioreactors and biomanufacturing solutions.
"Solaris Biotech was proud to be at the forefront of biomanufacturing innovation. Events like Analytica China provided invaluable opportunities to showcase our technologies and connect with like-minded industry professionals who were passionate about driving sustainable growth in biotechnology."
As we continue to grow our presence in the region, we look forward to deepening relationships with our new and existing customers. We are excited to explore the many opportunities ahead and to help drive innovation in biotechnology with sustainable and scalable solutions."
